Sinclair AJ, Pennells D, Abdelhafiz AH
This could mean consulting about adding bupropion , exploring microdosing strategies , requesting comprehensive hormone testing , or discussing whether switching to semaglutide might produce a different side effect profile for your individual biochemistry
This formulation is commonly prescribed as a starting dose to help patients gradually adjust to semaglutide therapy while minimizing gastrointestinal side effects
They arent banned, but theyre not approved per se
Focus on sipping water throughout the day and prioritizing protein to maintain muscle mass while your body adjusts to the new medication
Current Access Pathways in Canada Retatrutide remains in Phase 3 clinical trials with Health Canada approval expected following FDA decisions, typically 6-12 months after U.S